Compare PLETHICO PHARMA with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA DR. REDDYS LAB PLETHICO PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -1.1 21.6 - View Chart
P/BV x 0.0 3.2 0.5% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 PLETHICO PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
DR. REDDYS LAB
Mar-19
PLETHICO PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3952,875 13.7%   
Low Rs311,888 1.7%   
Sales per share (Unadj.) Rs604.4930.2 65.0%  
Earnings per share (Unadj.) Rs32.5117.4 27.7%  
Cash flow per share (Unadj.) Rs51.3185.8 27.6%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs473.6844.4 56.1%  
Shares outstanding (eoy) m34.08166.07 20.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.42.6 13.8%   
Avg P/E ratio x6.620.3 32.4%  
P/CF ratio (eoy) x4.212.8 32.4%  
Price / Book Value ratio x0.52.8 16.0%  
Dividend payout %017.0 0.0%   
Avg Mkt Cap Rs m7,262395,496 1.8%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m1,59633,562 4.8%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m20,598154,482 13.3%  
Other income Rs m3863,375 11.4%   
Total revenues Rs m20,984157,857 13.3%   
Gross profit Rs m2,81831,782 8.9%  
Depreciation Rs m64211,348 5.7%   
Interest Rs m1,593889 179.2%   
Profit before tax Rs m96922,920 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1383,858 -3.6%   
Profit after tax Rs m1,10719,500 5.7%  
Gross profit margin %13.720.6 66.5%  
Effective tax rate %-14.316.8 -84.9%   
Net profit margin %5.412.6 42.6%  
BALANCE SHEET DATA
Current assets Rs m18,877111,101 17.0%   
Current liabilities Rs m11,89658,973 20.2%   
Net working cap to sales %33.933.7 100.4%  
Current ratio x1.61.9 84.2%  
Inventory Days Days3679 45.3%  
Debtors Days Days19894 210.0%  
Net fixed assets Rs m9,861101,245 9.7%   
Share capital Rs m341830 41.0%   
"Free" reserves Rs m12,331139,406 8.8%   
Net worth Rs m16,139140,236 11.5%   
Long term debt Rs m4,70622,000 21.4%   
Total assets Rs m33,146224,656 14.8%  
Interest coverage x1.626.8 6.0%   
Debt to equity ratio x0.30.2 185.9%  
Sales to assets ratio x0.60.7 90.4%   
Return on assets %8.19.1 89.8%  
Return on equity %6.913.9 49.3%  
Return on capital %12.314.9 82.2%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,40288,673 5.0%   
Fx outflow Rs m3,18419,104 16.7%   
Net fx Rs m1,21969,569 1.8%   
CASH FLOW
From Operations Rs m2,43728,704 8.5%  
From Investments Rs m-6,265-7,727 81.1%  
From Financial Activity Rs m2,490-21,326 -11.7%  
Net Cashflow Rs m-1,337-314 425.8%  

Share Holding

Indian Promoters % 82.7 25.5 324.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 5.4 79.6%  
FIIs % 5.5 35.3 15.6%  
ADR/GDR % 0.0 18.5 -  
Free float % 7.5 15.3 49.0%  
Shareholders   10,665 75,885 14.1%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   PROCTER & GAMBLE HEALTH  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  ORCHID PHARMA LTD  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - FULFORD INDIA COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS